Expanding implementation of pediatric whole-genome sequencing: Insights from SeqFirst providers to inform equitable

Joon-Ho Yu1, Katherine E MacDuffie2, Olivia Sommerland3

  • 1University of Washington, Department of Pediatrics, Division of Genetic Medicine, Seattle, WA, USA; University of Washington, Institute for Public Health Genetics, Seattle, WA USA; Department of Pediatrics, Division of Bioethics and Palliative Care, University of Washington, Seattle, WA, USA; Seattle Children's Hospital and Research Institute, Seattle, WA, USA.

HGG Advances
|June 5, 2025
PubMed

Insights

Whole-genome sequencing (WGS) provides a direct path to precise genetic diagnoses for rare childhood conditions. However, provider perceptions of families can delay WGS access, impacting equitable healthcare delivery.

Area of Science:

  • Genetics
  • Pediatrics
  • Healthcare Access

Background:

  • Whole-genome sequencing (WGS) is a powerful diagnostic tool for rare genetic conditions in children.
  • Equitable access to genetic services, including WGS, is limited by various structural and social factors.
  • Disparities in access can stem from interactions between families, healthcare providers, and institutions.

Purpose of the Study:

  • To identify barriers and inform strategies for improving equitable access to precise genetic diagnoses (PrGD) through WGS.
  • To understand the perspectives of neonatologists and neurodevelopmental (NDV) providers regarding WGS implementation.
  • To explore how provider perceptions influence the introduction of WGS to families.

Main Methods:

  • Conducted semi-structured key informant interviews with 19 neonatologists and NDV providers.
  • Interviewees were involved in referring families to the SeqFirst study for WGS.
  • Qualitative data analysis to identify themes related to WGS access barriers.

Main Results:

  • Providers expressed enthusiasm for offering WGS despite varying medical contexts.
  • Key considerations influencing WGS introduction included perceptions of family capacity, readiness, and trust.
  • Provider-family rapport was also a significant factor in the timing and delivery of genetic testing information.
  • Findings suggest that providers' perceptions of families may lead to delayed WGS implementation.

Conclusions:

  • Provider perceptions of families and their social contexts present challenges and opportunities for WGS implementation.
  • Strategies are needed to promote and maximize equitable access to WGS for all children needing a precise genetic diagnosis.
  • Addressing provider biases and improving provider-family interactions are crucial for equitable WGS delivery.

Related Concept Videos

Next-generation Sequencing03:00

Next-generation Sequencing

The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
92.8K
Genomics02:02

Genomics

Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
37.6K
Sanger Sequencing01:57

Sanger Sequencing

DNA sequencing is a fundamental technique that is routinely used in the biological sciences. This method can be applied to a range of questions at different scales - from the sequencing of a cloned DNA fragment or the study of a mutation in a gene up to whole-genome sequencing. However, despite the widespread use of sequencing today, it was not until 1977 that Fredrick Sanger and his collaborators developed the chain-termination method to decode DNA sequences. It relies on the separation of a...
758.2K
Maxam-Gilbert Sequencing01:05

Maxam-Gilbert Sequencing

In the same year as the discovery of the Sanger sequencing method, another group of scientists, Allan Maxam and Walter Gilbert, demonstrated their chemical-cleavage method for DNA sequencing. The Maxam-Gilbert method relies on using different chemicals that can cleave the DNA sequence at specific sites, the separation of resulting DNA fragments of variable size using electrophoresis, and deciphering the DNA sequence from the resulting gel bands.
Challenges of the Maxam-Gilbert Method
The...
11.5K
RNA-seq03:21

RNA-seq

RNA sequencing, or RNA-Seq, is a high-throughput sequencing technology used to study the transcriptome of a cell. Transcriptomics helps to interpret the functional elements of a genome and identify the molecular constituents of an organism. Additionally, it also helps in understanding the development of an organism and the occurrence of diseases. 
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while...
10.4K